Media-OutReach Newswire Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire FrieslandCampina Hong Kong Donates Friso®GOLD Infant and Toddler Milk Formula to FOOD-CO of St. James’ Settlement
Media-OutReach Newswire Growthwell Group, One of South East Asia’s Leading Player for Plant-Based Alternatives Raises US$8 Million for Regional Scale-up